钠摄入量与妊娠期高血压疾病的发生
本研究为前瞻性Nulliparous妊娠结局研究的二次分析,纳入7458例孕前3个月完成食物频率问卷的单胎妊娠者。按每日钠摄入量分为低(<2 g)、中(2至<3 g)、高(≥3 g)三组,高钠组较低钠组发生妊娠期高血压疾病的调整发病率比值为1.17(95%CI 1.00-1.37)。结论认为钠摄入量与妊娠期高血压疾病风险无关。
要点
- 孕前3个月每日钠摄入量高(≥3 g)者与低(<2 g)者相比,妊娠期高血压疾病风险调整发病率比值为1.17(95%CI 1.00-1.37)。
- 中钠摄入(2至<3 g/天)与低钠摄入相比,调整发病率比值为1.10(95%CI 0.94-1.28)。
- 高钠摄入者更可能合并慢性高血压、吸烟和使用烟草及肥胖。
核心结论
- 钠摄入量与妊娠期高血压疾病的发生风险无关。
- 该无关联与非妊娠状态下钠摄入与高血压的关系形成对比,可能反映妊娠相关与非妊娠相关高血压疾病病理生理机制的差异。
研究设计与样本
- 本研究为前瞻性Nulliparous妊娠结局研究:监测准妈妈研究的二次分析。
- 纳入孕前3个月完成食物频率问卷并记录钠摄入量、非畸形单胎妊娠者,排除妊娠未超过20周者。
- 共纳入7458例,其中低钠摄入(<2 g/天)2336例(31%),中钠摄入(2至<3 g/天)2792例(37%),高钠摄入(≥3 g/天)2330例(31%)。
- 采用Kruskal-Wallis检验和卡方检验进行双变量分析,采用泊松回归估计调整发病率比值及95%置信区间。
主要发现
- 主要结局为新发妊娠期高血压疾病,包括妊娠期高血压、子痫前期、溶血、肝酶升高和低血小板计数综合征、慢性高血压并发子痫前期或子痫。
- 中钠摄入与低钠摄入相比,调整发病率比值为1.10(95%CI 0.94-1.28)。
- 高钠摄入与低钠摄入相比,调整发病率比值为1.17(95%CI 1.00-1.37)。
- 高钠摄入者更可能合并慢性高血压、吸烟及肥胖。
- 新生儿结局(包括早产、小于胎龄儿和新生儿重症监护病房入住)按钠摄入量分组无差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In nonpregnant populations, sodium intake has been associated with the development of chronic hypertension, and sodium restriction has been identified as a strategy to reduce blood pressure. Data regarding the relationship between sodium intake and the development of hypertensive disorders of pregnancy are limited and conflicting. OBJECTIVE: This study aimed to assess the association between daily periconceptional sodium intake and the risk of hypertensive disorders of pregnancy. STUDY DESIGN: This was a secondary analysis of the prospective Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-To-Be study. Individuals with nonanomalous, singleton pregnancies who completed food frequency questionnaires with recorded sodium intake in the 3 months before pregnancy were included in the analysis. Individuals whose pregnancies did not progress beyond 20 weeks of gestation were excluded from the analysis. Sodium intake was categorized as low (<2 g per day), medium (2 to <3 g per day), or high (≥3 g per day), based on thresholds used in the nonpregnant population. The primary outcome was the development of a new-onset hypertensive disorder of pregnancy, including gestational hypertension; preeclampsia; hemolysis, elevated liver enzymes, and low platelet count syndrome; superimposed preeclampsia; or eclampsia. Bivariable analyses were performed using Kruskal-Wallis and chi-square tests. Poisson regression was used to estimate adjusted incidence risk ratios with 95% confidence intervals after controlling for potentially confounding factors. RESULTS: Among 7458 individuals included in this analysis, 2336 (31%) reported low sodium intake, 2792 (37%) reported medium sodium intake, and 2330 (31%) reported high sodium intake. Individuals with high sodium intake were more likely to have chronic hypertension, to use tobacco, and to be living with obesity. The risk of developing a hypertensive disorder of pregnancy was similar among groups (medium vs low adjusted incidence risk ratio: 1.10 [95% confidence interval, 0.94-1.28]; high vs low adjusted incidence risk ratio: 1.17 [95% confidence interval, 1.00-1.37]). There was no difference in neonatal outcomes by sodium intake, including preterm birth, small-for-gestational-age neonate, and admission to the neonatal intensive care unit. CONCLUSION: Sodium intake was not associated with the risk of developing a hypertensive disorder of pregnancy. This lack of association contrasts with that between sodium intake and hypertension in the nonpregnant state and may reflect differences in the pathophysiology underlying pregnancy- vs non-pregnancy-related hypertensive disorders.
引用
- Bank TC, Grasch JL, Chung J, et al. Sodium intake and the development of hypertensive disorders of pregnancy. Am J Obstet Gynecol MFM. 2023. PMID: 37741626. doi:10.1016/j.ajogmf.2023.101166
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。